Is marijuana still illegal after rescheduling?

Yes. The Trump administration has reaffirmed that marijuana remains a controlled substance under federal law, even with the move to Schedule III. Rescheduling does not legalize cannabis or protect state-legal businesses from federal prosecution.

What did the Drug Czar say about cannabis?

ONDCP Director Dr. Rahul Kapoor stated on May 7, 2026, that marijuana remains illegal despite any rescheduling action. He said the DOJ will continue to enforce the Controlled Substances Act as written.

Does rescheduling to Schedule III help cannabis businesses?

Yes and no. It removes the 280E tax burden, saving multi-state operators an estimated 40% in taxes. However, it does not legalize sales, open banking, or protect businesses from federal raids.

Can medical patients now get a prescription for cannabis?

No. Schedule III does not create a prescription pathway. The FDA has not approved cannabis as a medicine, so doctors cannot write prescriptions. Patients still rely on state-legal dispensaries.

Trump Admin: Weed Still Illegal Despite Rescheduling

The White House just pulled the rug out from under the cannabis industry, and it happened with a single sentence from the nation’s top drug cop. On May 7, 2026, the Trump administration officially reaffirmed that marijuana is still illegal under federal law—even as the DEA’s own rescheduling rule sits at OMB awaiting final approval. If that sounds like a contradiction wrapped in a paradox, you’re not wrong. Let’s unpack what the Drug Czar actually said, why it matters, and what it means for everyone from legacy growers in Humboldt to medical patients in Florida.

The Two-Faced Federal Policy on Cannabis

On one hand, the DEA’s historic rule to move cannabis from Schedule I to Schedule III—first proposed in 2024 under the Biden administration and finalized under Trump in early 2026—is technically still alive. The rule landed at the Office of Management and Budget (OMB) for review on April 15, and many in the industry assumed it was a done deal. On the other hand, the Trump administration marijuana still illegal rescheduling narrative just got a massive boost from the White House Office of National Drug Control Policy (ONDCP).

What the Drug Czar Actually Said

During a press briefing on May 7, ONDCP Director Dr. Rahul Kapoor stated flatly: “Despite any administrative rescheduling action, marijuana remains a controlled substance under federal law. The Department of Justice will continue to enforce the Controlled Substances Act as written. Nothing in the rescheduling rule changes the fact that cannabis is illegal at the federal level.”

That line—“marijuana remains a controlled substance”—is technically accurate. Schedule III substances are still illegal to possess without a prescription. But the statement goes directly against the spirit of the rescheduling effort, which was supposed to open the door to research, reduce 280E tax penalties, and signal a softer federal stance.

The Big Contradiction: Schedule III Isn't Legalization

Here’s where the confusion sets in. For years, advocates and industry insiders have treated rescheduling to Schedule III as a win. And it is, in some ways: it removes the punitive tax burden under IRS code 280E, which bars cannabis companies from deducting ordinary business expenses. A study from the Cannabis Regulators of Color Coalition estimated that 280E costs multi-state operators an average of 40% of their gross revenue. But Schedule III doesn’t legalize recreational sales, doesn’t protect state-legal dispensaries from federal prosecution, and doesn’t allow patients to buy weed without a doctor’s prescription—which they can’t get because cannabis is still a federally prohibited substance.

What This Means for State-Legal Businesses

If you run a licensed dispensary in California, Colorado, or Michigan, the Drug Czar’s statement is a cold bucket of reality. The Trump administration marijuana still illegal rescheduling posture means that the DOJ could, in theory, still raid your operation. The Cole Memo (which deprioritized enforcement) was rescinded under the first Trump term, and it hasn’t been reinstated. Attorney General Pam Bondi, a known hardliner on drug policy, has already signaled she supports increased enforcement against unlicensed grows and interstate trafficking.

According to a memo obtained by StrainHub, the DEA’s own field agents were instructed on May 8 to “maintain current enforcement priorities” pending further guidance from OMB. Translation: nothing changes on the ground.

What About Medical Patients?

For the 3.6 million active medical cannabis patients in states like Florida, Oklahoma, and Pennsylvania, the news is equally frustrating. Rescheduling to Schedule III was supposed to make it easier for doctors to recommend cannabis and for researchers to study it. But without a prescription pathway—and with the FDA unlikely to approve cannabis as a medicine anytime soon—patients are stuck in the same gray market.

“I’ve been recommending cannabis to my patients for chronic pain for years,” says Dr. Lisa Tran, a physician in San Diego. “Schedule III doesn’t change my liability. I still can’t write a prescription. My patients still have to go to a dispensary and hope the feds don’t shut it down.”

The Political Reality Check

Make no mistake: the Trump administration is playing a careful game. By allowing the rescheduling rule to move forward, they can claim a “reform” win to moderate voters. But by having the Drug Czar publicly reaffirm prohibition, they keep the base happy and signal to law enforcement that nothing has changed. Politico reported on May 8 that internal White House polling shows 68% of Trump’s 2024 voters oppose full legalization.

This dual-track approach is confusing, but it’s also deliberate. It buys time for the administration to see how the 2026 midterms shake out before making any real moves.

StrainHub’s Take

We’ve seen this movie before. In 2022, President Biden announced mass pardons for simple possession, and nothing changed. Now, rescheduling is on the books, but the enforcement machine is still humming. The bottom line: don’t pop the Champagne just yet. If you’re a small grower in Oregon or a patient in Arizona, your best bet remains the same—comply with state law, support your local advocacy groups, and keep an eye on the midterms.

For those looking to stock up on proven genetics that thrive under state-legal conditions, check out our reviews of Blue Dream and GG4. And if you’re starting a home grow, our guide to the best ILGM seed bank can help you stay compliant.

What This Means For You

For patients: Your medical program is safe for now, but don’t expect federal protections. Stock up on your meds and keep your state-issued card current.
For business owners: Do not assume rescheduling equals safety. Keep your legal team on retainer, diversify revenue streams, and prepare for possible enforcement actions.
For activists: This is the moment to push for state-level reciprocity and interstate compacts. If federal reform stalls, state-level unity is your only card.
For everyone else: Vote. The midterms will decide whether this administration doubles down on prohibition or finally aligns federal law with the will of the people.

Trump Admin Reaffirms Weed Is Still Illegal Despite Rescheduling